manages the intellectual properties in cooperation with the ASAT Group Management. Patents covering the use of Melatonin, its indications and trade marks have been granted world wide. New patents have been filed.

Following patents are granted:

EP 1 235 571 B1 :
USE OF MELATONIN FOR TREATING ANDROGENETIC AND DIFFUSE FEMALE TYPE ALOPECIA

US 6,281,241 :
USE OF MELATONIN FOR THE TREATMENT OF ANDROGENETIC ALOPECIA